This user has not added any information to their profile yet.
Through our Integrated Data Solutions team, MIMS Australia makes its data available to third-party software developers for integration into medical software products e.g. GP and Specialist clinical solutions, acute care EHR and EMM solutions. Renowned as the gold standard of drug information for over 50 years in Asia-Pacific, MIMS serves medical professionals across countries such as; Australia, New Zealand, China, Malaysia, Philippines, Hong Kong, Singapore, India, South Korea, Vietnam, Taiwan and Thailand.
Over the years, clinicians have consistently cited MIMS as their No. 1 choice of drug reference. Today, nearly 1.8 million healthcare professionals rely on MIMS for timely access to authoritative drug information, medical news and continuing education resources.
Our Australian database and decision support modules are locally relevant, clinically reviewed, updated monthly and compatible with a host of clinical software solutions used across both the primary and acute care within the healthcare market. Indeed, the majority of Australian clinical and many dispensing solutions are supported by the MIMS medicines data base.
MIMS is built on a heritage of local expertise, credibility and adaptation to changing healthcare provider needs. Our information gathering, analysis and coding systems are proven and robust. MIMS information is backed by MIMS trusted, rigorous editorial process and constantly updated from a variety of sources including primary research literature.
In August 2016 MIMS acquired eHealthwise Services and as result can provide our partners with an award winning billing and claiming solution. Our Medicare ECLIPSE vendor certified THELMA platform interfaces to all major Vendor Systems, provides cost effective electronic claiming and makes claims tracking quick and efficient with full audit trail on all claims.
MIMS works with partners to provide both these solutions ensuring overseas organisations can simply and easily access the Australian (Prescription Benefit Scheme (PBS), local coding and evidenced clinical decision support and a billing/claiming system.
Our partners are supported by team that understands the local environment, has clinical, technical and business expertise.
In October 2015, SMS acquired MIMS Group jointly with Mitsui & Co. Ltd. (“Mitsui”). The collaborative investment, approximately valued at US$250 million had a respective split of SMS holding 60% and Mitsui holding 40%. This acquisition positions MIMS Group as one of the strongest players in integrated healthcare information business in the Asia Pacific region.